Literature DB >> 239881

Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation.

K Handa, S Sato.   

Abstract

The prerequisit of reduction for activation of Mitomycin-C and unstability of its reduced form suggested investigation of the possible formation of free radicals (semiquinone forms) of a series of quinone-containing anticancer chemicals in vitro. The ability of rat-liver microsomes to initiate sulfite oxidation in the presence of NADPH was markedly enhanced by the addition of these chemicals. This strongly suggests that these chemicals participated in the process in the form of reactive free radicals. The reaction was specific for NADPH. Carbazilquinone was unique among others in that NADH can replace NADPH and its higher ability to initiate sulfite oxidation. Microsomes from Ehrlich ascites and AH-109A hepatoma cells were also effective, though to a lesser extent than those from rat liver on a protein basis. Generation of free radicals, though their biological significance is not clear at present, may be deemed an inherent chemical property of these chemicals.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239881

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  36 in total

Review 1.  Free radical mediated cell toxicity by redox cycling chemicals.

Authors:  G M Cohen; M d'Arcy Doherty
Journal:  Br J Cancer Suppl       Date:  1987-06

2.  Cardiotoxic effects of anthracyclines.

Authors:  M R Bristow
Journal:  West J Med       Date:  1983-09

3.  Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.

Authors:  C U Ludwig; Y M Peng; J N Beaudry; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors:  N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Adriamycin-induced leakage of lysosomal enzymes in vitro.

Authors:  P K Singal; B MacLeod; C M Deally
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

7.  Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy.

Authors:  Jeriel T R Keeney; Sumitra Miriyala; Teresa Noel; Jeffrey A Moscow; Daret K St Clair; D Allan Butterfield
Journal:  Cancer Lett       Date:  2015-07-28       Impact factor: 8.679

8.  Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.

Authors:  G Joshi; C D Aluise; M P Cole; R Sultana; W M Pierce; M Vore; D K St Clair; D A Butterfield
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 9.  Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.

Authors:  L R Wiseman; C M Spencer
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

10.  Reactions of Adriamycin with haemoglobin. Superoxide dismutase indirectly inhibits reactions of the Adriamycin semiquinone.

Authors:  D A Bates; C C Winterbourn
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.